Biognosys

Biognosys

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $60.5M

Overview

Founded in 2008 and headquartered in Schlieren, Switzerland, Biognosys has established itself as a premier proteomics contract research organization (CRO) and technology provider. The company's core strength lies in its patented mass spectrometry workflows and its flagship Spectronaut software suite, which enable deep, quantitative analysis of thousands of proteins across thousands of samples. Through strategic partnerships and continuous innovation, Biognosys is expanding its service offerings into multiomics and high-throughput applications, positioning itself as a critical enabler for biomarker discovery and precision medicine.

ProteomicsAI / Machine Learning

Technology Platform

Proprietary mass spectrometry workflows (DIA), AI-powered software suite (Spectronaut), and sample preparation kits for next-generation proteomics.

Funding History

5
Total raised:$60.5M
Grant$2.5M
Series B$20M
Series B$22M
Series A$8M

Opportunities

The rapid growth of precision medicine and biomarker-driven drug development creates massive demand for large-scale, high-quality proteomic data.
Expansion into multiomics (e.g., metabolomics) and high-throughput clinical services allows Biognosys to address broader research questions and capture more value from each client.

Risk Factors

Faces competition from other proteomics CROs and large diagnostic companies.
Technological disruption from new analytical platforms is a constant risk.
As a private company, scaling operations globally may be constrained by access to capital compared to public competitors.

Competitive Landscape

Competes with other specialized proteomics CROs (e.g., Olink, SomaLogic via different technologies), large life science tools companies (e.g., Thermo Fisher, Agilent), and the in-house capabilities of large pharma. Its differentiation lies in its depth of DIA expertise, integrated software-hardware ecosystem, and focus on large-scale, unbiased discovery.